Search research articles
Contact Us
Filters
Showing results (61-70 of 247) with videos related to
Page
of 25
Sort By:
Future Microbiology
|
May 25, 2013
Pharmacology of polymyxins: new insights into an 'old' class of antibiotics
Tony Velkov, Kade D Roberts, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy
|
October 11, 2017
Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes
Rajbharan Yadav, Jürgen B Bulitta, Jiping Wang, et al.
International Journal of Antimicrobial Agents
|
December 29, 2004
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Jian Li, Roger L Nation, Robert W Milne, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 2011
Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics
Jumana M Yousef, Gong Chen, Prue A Hill, et al.
American Journal of Pharmaceutical Education
|
April 24, 2010
A palliative cancer care flexible education program for Australian community pharmacists
Safeera Yasmeen Hussainy, Jennifer L Marriott, Jill Beattie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2007
Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains
Jian Li, Roger L Nation, Roxanne J Owen, et al.
Journal of Pharmaceutical Sciences
|
May 25, 2012
Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation
Stephanie J Wallace, Jian Li, Roger L Nation, et al.
Infectious Disease Clinics of North America
|
May 22, 2016
Agents of Last Resort: Polymyxin Resistance
Keith S Kaye, Jason M Pogue, Thien B Tran, et al.
Pharmaceutics
|
September 25, 2019
Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable <i>Pseudomonas Aeruginosa</i> Strains via Mechanism-Based Modelling
Vanessa E Rees, Jürgen B Bulitta, Antonio Oliver, et al.
ACS Pharmacology & Translational Science
|
June 23, 2020
Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery
Cornelia B Landersdorfer, Martina Kinzig, Rainer Höhl, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 247) with videos related to
Sort By:
Page
of 25
Future Microbiology
|
May 25, 2013
Pharmacology of polymyxins: new insights into an 'old' class of antibiotics
Tony Velkov, Kade D Roberts, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy
|
October 11, 2017
Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes
Rajbharan Yadav, Jürgen B Bulitta, Jiping Wang, et al.
International Journal of Antimicrobial Agents
|
December 29, 2004
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Jian Li, Roger L Nation, Robert W Milne, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 2011
Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics
Jumana M Yousef, Gong Chen, Prue A Hill, et al.
American Journal of Pharmaceutical Education
|
April 24, 2010
A palliative cancer care flexible education program for Australian community pharmacists
Safeera Yasmeen Hussainy, Jennifer L Marriott, Jill Beattie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2007
Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains
Jian Li, Roger L Nation, Roxanne J Owen, et al.
Journal of Pharmaceutical Sciences
|
May 25, 2012
Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation
Stephanie J Wallace, Jian Li, Roger L Nation, et al.
Infectious Disease Clinics of North America
|
May 22, 2016
Agents of Last Resort: Polymyxin Resistance
Keith S Kaye, Jason M Pogue, Thien B Tran, et al.
Pharmaceutics
|
September 25, 2019
Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable <i>Pseudomonas Aeruginosa</i> Strains via Mechanism-Based Modelling
Vanessa E Rees, Jürgen B Bulitta, Antonio Oliver, et al.
ACS Pharmacology & Translational Science
|
June 23, 2020
Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery
Cornelia B Landersdorfer, Martina Kinzig, Rainer Höhl, et al.
Page
of 25